Ambu EBITDA Margin 2022-2026 | AMBBY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Ambu (AMBBY) over the last 10 years. The current EBITDA margin for Ambu as of March 31, 2026 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Ambu EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2026-03-31 $0.95B $0.16B 17.19%
2025-12-31 $0.92B $0.17B 17.92%
2025-09-30 $0.89B $0.17B 19.13%
2025-06-30 $0.87B $0.17B 19.59%
2025-03-31 $0.84B $0.17B 19.79%
2024-12-31 $0.82B $0.16B 19.90%
2024-09-30 $0.78B $0.15B 18.75%
2024-06-30 $0.76B $0.14B 18.22%
2024-03-31 $0.74B $0.13B 17.21%
2023-12-31 $0.71B $0.10B 14.51%
2023-09-30 $0.69B $0.09B 13.43%
2023-06-30 $0.66B $0.06B 9.53%
2023-03-31 $0.65B $0.05B 7.88%
2022-12-31 $0.65B $0.05B 8.06%
2022-09-30 $0.65B $0.05B 7.42%
Sector Industry Market Cap Revenue
Medical Medical - Hospitals $2.408B $0.894B
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark.
Stock Name Country Market Cap PE Ratio
Tenet Healthcare (THC) United States $21.095B 13.55
Universal Health Services (UHS) United States $10.414B 7.63
Acadia Healthcare (ACHC) United States $2.638B 18.40
Community Health Systems (CYH) United States $0.405B 4.78